Subscribe to RSS
DOI: 10.1055/s-2005-923595
Aryldiazirine-Modified Pyroglutamates: Photoaffinity Labels for Glutamate
Publication History
Publication Date:
23 December 2005 (online)
Abstract
The synthesis of an aryldiazirine-modified pyroglutamate is reported for potential application as a photoaffinity label at glutamate receptors. Detailed 13C NMR and 19F NMR spectroscopic characterisation data for these trifluoromethyl-substituted aryldiazirines has been determined and shown to be useful for tracking this group during synthesis.
Key words
glutamate - photoaffinity - diazirines
- 1
Michaelis E. Prog. Neurobiol. 1998, 54: 369 - 2
Moloney MG. Nat. Prod. Rep. 2002, 19: 597 - 3
Grazioso G.Moretti L.Scapozza L.Arnici MD.Micheli CD. J. Med. Chem. 2005, 48: 5489 - 4
Fedoryak O.Sul J.-Y.Haydon PG.Ellis-Davies GCR. Chem. Commun. 2005, 3664 - 5
Kotzyba-Hibert F.Kapfer I.Goeldner M. Angew. Chem., Int. Ed. Engl. 1995, 34: 1296 - 6
Fleming SA. Tetrahedron 1995, 51: 12479 - 7
Bayley H. Photogenerated Reagents in Biochemistry and Molecular Biology Vol. 12:Work TS.Burdon RH. Elsevier; Amsterdam: 1983. - 8
Blencowe A.Hayes W. Soft Matter 2005, 1: 178 - 9
Hatanaka Y.Nakayama H.Kanaoka Y. Rev. Heteroatom. Chem. 1996, 14: 213 - 10
Baldwin JE.Coates JB.Moloney MG.Pratt AJ.Willis AC. Biochem. J. 1990, 266: 561 - 11
Marti T.Benke D.Mertens S.Heckendorn R.Pozza M.Allgeier H.Angst C.Laurie D.Seeburg P.Mohler H. Proc. Natl. Acad. Sci. U.S.A. 1993, 90: 8434 - 12
Benke D.Marti T.Heckendorn R.Rehm H.Künzi R.Allgeier H.Angst C.Mohler H. Eur. J. Pharmacol., Mol. Pharmacol. 1993, 246: 179 - 13
Willis CL.Wacker DA.Bartlett RD.Bleakman D.Lodge D.Chamberlin AR.Bridges RJ. J. Neurochem. 1997, 68: 1503 - 14
Niu L.Gee KR.Schaper K.Hess GP. Biochemistry 1996, 35: 2030 - 15
Sivvas E.Voukelatou G.Papaioannou D.Aletras AJ.Kouvelas ED. J. Neurochem. 1994, 63: 1544 - 16
Sivvas E.Voukelatou G.Kouvelas ED.Francis GW.Aksnes DW.Papaioannou D. Acta Chem. Scand. 1994, 48: 76 - 17
Wacker DA.Lovering FE.Bridges RJ.Willis C.Bartlett R.Chamberlin AR. Synlett 1997, 503 - 18
Huang Y.Narendran R.Bischoff F.Guo N.Zhu Z.Bae SA.Lesage AS.Laruelle M. J. Med. Chem. 2005, 48: 5096 - 19
Hatanaka Y.Hashimoto M.Kurihara H.Nakayama H.Kanaoka Y. J. Org. Chem. 1994, 59: 383 - 20
Weber T.Brunner J. J. Am. Chem. Soc. 1995, 117: 3084 - 21
Hashimoto M.Kanaoka Y.Hatanaka Y. Heterocycles 1997, 46: 119 - 22
Hashimoto M.Komano T.Nabeta K.Hatanaka Y. Chem. Pharm. Bull. 2005, 53: 140 - 23
Kurono M.Shimomura A.Isobe M. Tetrahedron 2004, 60: 1773 - 24
Hashimoto M.Nabeta K.Murakami K. Bioorg. Med. Chem. Lett. 2003, 13: 1531 - 25
Hashimoto M.Hatanaka Y.Nabeta K. Heterocycles 2003, 59: 395 - 26
Hashimoto M.Hatanaka Y.Nabeta K. Bioorg. Med. Chem. Lett. 2002, 12: 89 - 27
Hashimoto M.Hatanaka Y.Yang J.Dhesi J.Holman GD. Carbohydr. Res. 2001, 331: 119 - 28
Hashimoto M.Hatanaka Y.Nabeta K. Bioorg. Med. Chem. Lett. 2000, 10: 2481 - 29
Hatanaka Y.Kempin U.Jong-Jip P. J. Org. Chem. 2000, 65: 5639 - 30
Ruhl T.Hennig L.Hatanaka Y.Burger K.Welzel P. Tetrahedron Lett. 2000, 41: 4555 - 31
Kempin U.Kanaoka Y.Hatanaka Y. Heterocycles 1998, 49: 465 - 32
Hashimoto M.Hatanaka Y.Sadakane Y.Nabeta K. Bioorg. Med. Chem. Lett. 2002, 12: 2507 - 33
Baldwin JE.Pratt AJ.Moloney MG. Tetrahedron 1987, 43: 2565 - 34
Deacon G.O’Connor M.Stretton GN. Austr. J. Chem. 1986, 39: 953 - 35
Dyer J.Keeling S.King A.Moloney MG. J. Chem. Soc., Perkin Trans. 1 2000, 2793 - 38
Morgan J.Pinhey JT. J. Chem. Soc., Perkin Trans. 1 1990, 715 - 39
Fletcher DA.McMeeking RF.Parkin D. J. Chem. Inf. Comput. Sci. 1996, 36: 746
References and Notes
Data for Lactam 5.
Obtained as a colourless oil (0.111 g, 23%); R
f
= 0.20 [PE(40-60 °C)-EtOAc, 5:1]. 1H NMR (400 MHz, CDCl3): δ = 1.30 (3 H, t, J = 7.0 Hz, CH3CH2), 1.47 [9 H, s, C(CH3)3], 2.66 (2 H, d, J = 7.6 Hz, CH2CO2
t-Bu), 3.09-3.15 [1 H, m, H(6)], 3.23 (2 H, dd, J = 13.9 Hz, CH2Ph), 3.33 (3 H, s, OCH3), 3.60-3.66 [1 H, m, H(5)], 3.76-4.26 [2 H, m, H(4)], 4.30-4.34 (2 H, m, CH3CH2), 6.21 [1 H, s, H(2)], 6.39 (1 H, s, ArH ortho to OMe)], 6.47 (1 H, d, J = 8.0 Hz, ArH para to OMe), 7.23 (1 H, d, J = 8.0 Hz, ArH meta to OMe), 7.27-7.44 (5 H, m, PhH). 13C NMR (400 MHz, CDCl3): δ = 14.1 (CH3CH2), 28.1 [C(CH3)3], 28.3 (CH2Ph), 33.9 (CH2CO2
t-Bu), 45.9 [C(6)], 54.7 (OCH3), 61.9 [C(5)], 62.0 (CO2CH2CH3), 63.9 [C(7)], 72.8 [C(4)], 86.9 [C(2)], 107.8 (ArC ortho to OMe), 118.3 (ArH para to OMe), 126.0, 126.5, 128.4, 128.7, 128.9 (all ArCH), 127.4 (q, J = 280.5 Hz, CF3), 126.1, 129.1 (ArC), 132.6 [C(15)], 138.3 [(C(13)], 157.6 [C(11)], 170.6 (lactam C=O), 170.8 (ethyl ester C=O), 171.7 (t-Bu ester C=O). IR (thin film): νmax = 2981 (s, aliphatic C-H), 1728 (br s, ester and lactam C=O), 1261 (s, C-O), 1039 (s, C-F) cm-1.
Data for Lactam 6.
Obtained as a colourless oil (0.0198 g, 24%). R
f
= 0.23 [EtOAc-PE (40-60 °C), 6:5]. 1H NMR ( 400 MHz, CDCl3): δ = 2.73-2.85 (2 H, m, CH2CO2Me), 3.22 (2 H, dd, J = 14.7 Hz, CH2Ph), 3.52-3.62 [1 H, m, H(3)], 3.70, 3.74, 3.77, 3.79 (4 × 3 H, s, OCH3), 3.69-3.76 [1 H, m, H(2)], 6.31 (1 H, s, NH), 6.55 (1 H, s, ArH ortho to OMe), 6.69 (1 H, d, J = 7.9 Hz, ArH para to OMe), 7.37 (1 H, d, J = 8.0 Hz, ArH meta to OMe). 13C NMR (400 MHz, CDCl3): δ = 27.2 (CH2Ph), 28.6 [C(3)], 32.3 (CH2CO2Me), 43.9 [C(2)], 52.0, 52.8, 53.0 (OCH3), 55.2 (ArOCH3), 58.6 [C(4)], 108.0 (ArC ortho to OMe), 118.7 (ArC para to OMe), 122.0 (q, J = 274.7 Hz, CF3), 126.2 (ArC ortho to OMe), 129.3 (ΑρΧ), 131.7 (ΑρΧ), 157.6 [Χ(8)], 170.3, 170.7, 171.4 (Χ=Ο εστερσ), 173.0 (Χ=Ο λαχταµ). ΙΡ (τηιν φιλµ): νmax = 3020, 2956 (m, C-H), 2401 (m, N=N), 1740 (s, C=O), 1577, 1515 (m, Ar C=C), 1216 (s, C-O), 1039 (s, C-F) cm-1.